AAPL   323.34 (+0.00%)
MSFT   184.26 (-0.36%)
FB   229.84 (-1.24%)
GOOGL   1,435.81 (-0.45%)
AMZN   2,471.00 (-0.06%)
NVDA   349.55 (-0.98%)
BABA   215.40 (+0.50%)
MU   48.22 (+2.99%)
GE   7.23 (+2.55%)
AMD   52.61 (-1.76%)
ACB   14.37 (-1.10%)
F   6.14 (+3.90%)
GILD   74.15 (+1.21%)
DIS   121.92 (+2.67%)
BAC   26.05 (+4.87%)
AAPL   323.34 (+0.00%)
MSFT   184.26 (-0.36%)
FB   229.84 (-1.24%)
GOOGL   1,435.81 (-0.45%)
AMZN   2,471.00 (-0.06%)
NVDA   349.55 (-0.98%)
BABA   215.40 (+0.50%)
MU   48.22 (+2.99%)
GE   7.23 (+2.55%)
AMD   52.61 (-1.76%)
ACB   14.37 (-1.10%)
F   6.14 (+3.90%)
GILD   74.15 (+1.21%)
DIS   121.92 (+2.67%)
BAC   26.05 (+4.87%)
AAPL   323.34 (+0.00%)
MSFT   184.26 (-0.36%)
FB   229.84 (-1.24%)
GOOGL   1,435.81 (-0.45%)
AMZN   2,471.00 (-0.06%)
NVDA   349.55 (-0.98%)
BABA   215.40 (+0.50%)
MU   48.22 (+2.99%)
GE   7.23 (+2.55%)
AMD   52.61 (-1.76%)
ACB   14.37 (-1.10%)
F   6.14 (+3.90%)
GILD   74.15 (+1.21%)
DIS   121.92 (+2.67%)
BAC   26.05 (+4.87%)
AAPL   323.34 (+0.00%)
MSFT   184.26 (-0.36%)
FB   229.84 (-1.24%)
GOOGL   1,435.81 (-0.45%)
AMZN   2,471.00 (-0.06%)
NVDA   349.55 (-0.98%)
BABA   215.40 (+0.50%)
MU   48.22 (+2.99%)
GE   7.23 (+2.55%)
AMD   52.61 (-1.76%)
ACB   14.37 (-1.10%)
F   6.14 (+3.90%)
GILD   74.15 (+1.21%)
DIS   121.92 (+2.67%)
BAC   26.05 (+4.87%)
Log in

FRA:SRT3Sartorius Stock Price, Forecast & News

€317.80
-4.20 (-1.30 %)
(As of 06/3/2020 08:05 AM ET)
Add
Compare
Today's Range
€314.80
Now: €317.80
€324.20
50-Day Range
€224.40
MA: €278.96
€333.40
52-Week Range
€71.00
Now: €317.80
€124.70
Volume31,134 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sartorius Aktiengesellschaft supplies pharmaceutical and laboratory equipment worldwide. It operates in two divisions, Bioprocess Solutions, and Lab Products & Services. The company offers products for suspension cell analysis and live-cell analysis inside incubator for oncology, immuno-oncology, antibody discovery, neuroscience, and stem cell research; cell culture media, including antibody and recombinant protein, viral vaccines, and regenerative medicine media, as well as general media and downstream buffers; and multi-parallel, single-use, benchtop, stainless steel, microbial, and cell culture bioreactors, as well as cell culture expansion systems and software applications for bioreactors. It also provides lab filtration and purification devices; sterile and virus filtration, crossflow filtration, harvesting, prefiltration, membrane chromatography, air/gas filtration, and integrity testing devices; and liquid storage and shipping, freeze and thaw, mixing, proven integrity, transferring and sampling, connecting and disconnecting, and final filling management products. In addition, the company offers process control and data analytics products, such as process analyzers, automation modules, and data analytics and chemometrics; and microbiology products, and lab water purification systems. Further, it provides lab balances, mass comparators and metrology, moisture analyzers, specialty weighing solutions, weighing accessories, weights/weight sets, paint mixing solutions, and OEM weigh cells; and OEM membrane and device, pipetting and dispensing, and connectivity solutions. Additionally, the company offers bioprocess development engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, food and beverage, environmental, and paint mixing industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Read More
Sartorius logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.1Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.81 out of 5 stars


Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-551-3080

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees8,500
Next Earnings DateN/A
OptionableNot Optionable

Receive SRT3 News and Ratings via Email

Sign-up to receive the latest news and ratings for SRT3 and its competitors with MarketBeat's FREE daily newsletter.

Sartorius (FRA:SRT3) Frequently Asked Questions

How has Sartorius' stock been impacted by COVID-19 (Coronavirus)?

Sartorius' stock was trading at €199.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SRT3 stock has increased by 59.7% and is now trading at €317.80. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Sartorius?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sartorius in the last year. There are currently 2 sell ratings, 5 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Sartorius.

What price target have analysts set for SRT3?

10 analysts have issued twelve-month price targets for Sartorius' shares. Their forecasts range from €135.00 to €327.00. On average, they anticipate Sartorius' share price to reach €212.50 in the next twelve months. This suggests that the stock has a possible downside of 33.1%. View analysts' price targets for Sartorius.

Has Sartorius been receiving favorable news coverage?

News headlines about SRT3 stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Sartorius earned a news sentiment score of 1.7 on InfoTrie's scale. They also gave headlines about the company a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the stock's share price in the next several days. View the latest news aboutSartorius.

Who are some of Sartorius' key competitors?

What other stocks do shareholders of Sartorius own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sartorius investors own include Basf (BAS), Barclays (BARC), Alibaba Group (BABA), Boeing (BA), AstraZeneca (AZN), Advanced Micro Devices (AMD), Allianz (ALV), Alliance Data Systems (ADS), adidas (ADS) and Accenture (ACN).

Who are Sartorius' key executives?

Sartorius' management team includes the following people:
  • Dr. Joachim Kreuzburg, Chairman of Exec. Board & CEO (Age 54)
  • Mr. Rainer Lehmann, CFO & Member of Exec. Board and Head of Fin., Information Technology & Bus. Process (Age 43)
  • Ms. Petra Kirchhoff, Head of Corp. Communications & Investor Relations and Member of Supervisory Board (Age 50)
  • Mr. Gerry Mackay, Head of Lab Products & Services Division & Member of Exec. Board (Age 56)
  • Dr. René Fáber, Head of Bioprocess Solutions Division & Member of Exec. Board (Age 43)

What is Sartorius' stock symbol?

Sartorius trades on the FRA under the ticker symbol "SRT3."

What is Sartorius' stock price today?

One share of SRT3 stock can currently be purchased for approximately €317.80.

What is Sartorius' official website?

The official website for Sartorius is www.sartorius.de.

How can I contact Sartorius?

Sartorius' mailing address is Weender Landstrasse 94-108, GOETTINGEN, 37075, Germany. The company can be reached via phone at +49-551-3080.

This page was last updated on 6/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.